CYBRD1 and ovarian serous cystadenocarcinoma: A study helmed by Chen and collaborators [40] underscored that CYBRD1, potentially indicative of ovarian serous cystadenocarcinoma (OV), witnessed pronounced elevations in OV, with its surges linked to factors like lymphatic dissemination, disease progression, and clinical trajectories less favorable.